Related Experiment Video
Updated: May 7, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Epigenetics of diabetic complications
Louisa M Villeneuve1, Rama Natarajan
1Division of Diabetes, Beckman Research Institute of City of Hope, 1500 E. Duarte Road, Duarte, CA-91010, USA.
Expert Review of Endocrinology & Metabolism
|October 1, 2013
Summary
Epigenetics, including DNA methylation, plays a role in diabetic complications by altering gene regulation. Understanding these epigenetic changes may reveal new therapeutic targets for diabetes.
Area of Science:
- Endocrinology and Metabolism
- Epigenetics
- Molecular Biology
Background:
- Type 1 and Type 2 diabetes are complex diseases with numerous genetic and environmental contributing factors.
- While diabetes genetics are well-studied, the mechanisms driving its complications are not fully understood.
- Epigenetic mechanisms, such as DNA methylation and histone modifications, offer insights into gene-environment interactions in disease.
Purpose of the Study:
- To explore the role of epigenetics in the development and perpetuation of diabetic complications.
- To investigate how epigenetic modifications, specifically histone methylation, are altered in diabetic conditions.
- To examine the potential involvement of epigenetic mechanisms in the metabolic memory phenomenon observed in diabetes.
Main Methods:
- Analysis of DNA methylation patterns in target cells under diabetic conditions.
- Assessment of epigenetic chromatin histone methylation patterns in diabetic models.
- Review of recent evidence linking epigenetic alterations to diabetic complications and metabolic memory.
Main Results:
- Diabetic conditions alter key biochemical pathways and epigenetic chromatin histone methylation patterns.
- These epigenetic changes may contribute to the progression of diabetic complications.
- Evidence suggests a role for epigenetics in the metabolic memory phenomenon in diabetes.
Conclusions:
- Epigenetic mechanisms are crucial for understanding the interplay between genes and environment in diabetes.
- Altered epigenetic patterns in diabetic conditions may perpetuate complications, even with glycemic control.
- Further study of epigenetic mechanisms could lead to novel therapeutic targets for managing diabetic complications.
Related Concept Videos
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...